Spots Global Cancer Trial Database for Minimum Dose CT Post Lung Biopsy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Minimum Dose CT Post Lung Biopsy
Official Title: Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?
Study ID: NCT00188162
Conditions
Interventions
Study Description
Brief Summary: The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy
Detailed Description: Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax
Keywords
Eligibility
Minimum Age: 16 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Toronto General Hospital, Toronto, Ontario, Canada
Contact Details
Name: Narinder Paul, FRCP C
Affiliation: University Health Network, Toronto
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
